Iritis
Showing 1 - 25 of 209
Herpes Zoster Ophthalmicus Trial in Canada, United States (Masked Placebo, Masked Oral Valacyclovir)
Active, not recruiting
- Herpes Zoster Ophthalmicus
- Masked Placebo
- Masked Oral Valacyclovir
-
Birmingham, Alabama
- +77 more
Jan 17, 2023
Inflammatory Marker in Ibd and Peripheral Arthritis
Not yet recruiting
- IBD-Inflammatory Bowel Disease
- (no location specified)
Jan 20, 2023
Diabetic Retinopathy, Vitreomacular Traction Trial in Minya (Methotrexate 25 MG/ML, parsplana vitrectomy)
Recruiting
- Diabetic Retinopathy
- Vitreomacular Traction
- Methotrexate 25 MG/ML
- parsplana vitrectomy
-
Minya, Minia, Egyptophthalmology department, Minia university hospital
Sep 8, 2023
Primary Open Angle Glaucoma Trial in United States (Hydrus Microstent)
Recruiting
- Primary Open Angle Glaucoma
- Hydrus Microstent
- +2 more
-
Sacramento, California
- +12 more
Dec 16, 2022
Advanced Retinitis Pigmentosa Trial in United States (RST-001)
Active, not recruiting
- Advanced Retinitis Pigmentosa
-
San Francisco, California
- +3 more
Sep 9, 2022
Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,
Not yet recruiting
- Corneal Edema
- +6 more
- Dextenza 0.4Mg Ophthalmic Insert
- +3 more
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 5, 2022
Ocular Inflammation Trial (ISV-303, DuraSite Vehicle)
Diabetic Retinopathy, Diabetic Cataract Trial in Guangzhou (Pars plana vitrectomy combined with cataract surgery., Pars plana
Completed
- Diabetic Retinopathy
- Diabetic Cataract
- Pars plana vitrectomy combined with cataract surgery.
- Pars plana vitrectomy with subsequent cataract surgery.
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic center, Sun Yat-sen University
Sep 8, 2022
Immersive VR Environments to Induce and Evaluate Cognitive
Recruiting
- Cognitive Fatigue
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Crohn Disease, Nutrient; Excess, Remission/Regression Trial in Duzce (EEN (Nestle Modulen®), Standart of care)
Recruiting
- Crohn Disease
- +2 more
- EEN (Nestle Modulen®)
- Standart of care
-
Duzce, TurkeyDuzce University School of Medicine
Oct 15, 2022
Glaucoma Trial in Buffalo (KDB/Phacoemulsification, Trabectome/Phacoemulsification)
Active, not recruiting
- Glaucoma
- KDB/Phacoemulsification
- Trabectome/Phacoemulsification
-
Buffalo, New YorkThe Ira G. Ross Eye Institute
Sep 26, 2021
Cataract Extraction Trial in Venice, Washington, Lake Jackson (Capsular Tension Ring)
Recruiting
- Cataract Extraction
- Capsular Tension Ring
-
Venice, Florida
- +2 more
Jun 14, 2021
Melanoma Trial in Aurora (VESANOID, Ipilimumab)
Active, not recruiting
- Melanoma
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 7, 2022
Anterior Uveitis, Iritis Trial in Boston (PEMF, PEMF Placebo)
Completed
- Anterior Uveitis
- Iritis
- PEMF
- PEMF Placebo
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Jan 31, 2018
Pain, Inflammation Trial in Edgewood, Garden City, Mount Pleasant (Nepafenac PPDS, Placebo PPDS)
Completed
- Pain
- Inflammation
- Nepafenac PPDS
- Placebo PPDS
-
Edgewood, Kentucky
- +2 more
Sep 16, 2021
Myopia, Hyperopia, Astigmatism Trial in United States (Invigor A (test), Invigor B (control))
Completed
- Myopia
- +2 more
- Invigor A (test)
- Invigor B (control)
-
Torrance, California
- +5 more
Sep 10, 2020
DEXYCU 9% Retrospective Study 001
Completed
- Cataract
- DEXYCU (dexamethasone intraocular suspension) 9%.
-
Dothan, Alabama
- +21 more
May 24, 2021
Inflammation and Pain Associated With Cataract Surgery Trial in Memphis (ISV-305, Vehicle)
Completed
- Inflammation and Pain Associated With Cataract Surgery
- ISV-305
- Vehicle
-
Memphis, TennesseeClinical Research Center
Nov 18, 2021
Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)
Completed
- Diabetic Macular Edema
- Retina Vein Occlusion
-
Phoenix, Arizona
- +5 more
Nov 18, 2021
DLQI, PHQ-9, PSAI Trial in Hualien City (Jing Si herbal tea liquid packets use)
Recruiting
- DLQI
- +3 more
- Jing Si herbal tea liquid packets use
-
Hualien City, Hualien, TaiwanHualien Tzu Chi Hospital
Jun 23, 2022
Inflammation Corneal, Pain, Postoperative Trial in United States (OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic
Completed
- Inflammation Corneal
- Pain, Postoperative
- OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL
- Placebo
-
Petaluma, California
- +3 more
Feb 17, 2022